FDA Import Refusal 799-4655536-3/21/1 — Glaxosmithkline Peru Sa
The FDA refused shipment 799-4655536-3/21/1 from Glaxosmithkline Peru Sa (Peru) on Sep 27, 2021. The refused product falls under Drugs and Biologics — FLUTICASONE PROPIONATE (BRONCHODILATOR). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Sep 27, 2021
- Country
- Peru
- Product Category
- Drugs and Biologics
- Product Code
- 63BDY25 FLUTICASONE PROPIONATE (BRONCHODILATOR)
- Charges
- 75